Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01981109 · ClinicalTrials.gov registry record
Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer
A clinical trial, sponsored by Dendreon.
- Terminated
- Registry status
- 225
- Enrollment target
NCT01981109: Clinical Trial study, sponsored by Dendreon.
NCT01981109 is a clinical trial that was terminated before completion, run by Dendreon. The registered enrollment target is 225 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01981109 was terminated before completion, sponsored by Dendreon.
- TERMINATED
- Registry status
- 225 participants
- Enrollment target
Study Summary
The primary purpose of this research is to describe patient characteristics predictive of an imaging study positive for distant metastases in patients with castration-resistant prostate cancer and no known distant metastases.
Primary Outcome
The primary endpoint for the study will be the occurrence of an imaging study at baseline that is positive for M1 (yes or no) among all patients in the primary analysis population.The primary analysis population consists of patients who had a current diagnosis of having non metastatic (M0) disease at baseline. These patients underwent imaging scans at baseline and were assessed for metastatic (M1) versus non metastatic (M0) disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 225 participants |
| Start Date | 2012-01 |
| Est. Completion | 2017-07 |
Why NCT01981109 stopped before completion
NCT01981109 is an observational study that tracks outcomes without assigning an intervention. The registered 225 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01981109 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01981109 about?
NCT01981109 is a clinical study titled "Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer". The primary purpose of this research is to describe patient characteristics predictive of an imaging study positive for distant metastases in patients with castration-resistant prostate cancer and no known distant metastases.
What is the current status of trial NCT01981109?
This trial is currently terminated. The enrollment target is 225 participants. The study started on 2012-01. Estimated completion is 2017-07.
Who is sponsoring clinical trial NCT01981109?
This trial is sponsored by Dendreon, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03955445 · 225 participants · Phase 3
Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
- NCT04054310 · 225 participants · NA
Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
- NCT04480554 · 225 participants · Phase 2
Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1
- NCT04888104 · 225 participants
Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia